Comparison of pimecrolimus and microneedling effects in the treatment of vitiligo
Phase 3
Recruiting
- Conditions
- vitiligo.Vitiligo
- Registration Number
- IRCT20190521043664N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Written consent to participate in the study
Stability of the disease within the last year if the disease has not progressed in the last year
Existence of lesions on the trunk and limb
Patients who did not respond appropriately to phototherapy, topical and systemic therapy.
Exclusion Criteria
Pregnancy and lactation
Active vitiligo lesion
Sensitivity to pimecrolimus
Administration of systemic and topical treatments for vitiligo one month before enrollment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Photographic Scoring for patients with vitiligo. Timepoint: Before and 9 months after the study. Method of measurement: Score to photography.
- Secondary Outcome Measures
Name Time Method